Sheng and colleagues demonstrated that PARP inhibition induced cytosolic double-stranded DNA, thereby activating the STING pathway and promoting tumour-infiltrating lymphocytes and antitumour immunity [141]. The gene discussed is PARP1; the disease is neoplasm.